General Statement of India to the WIPO General Assembly 2012 (raises concerns on public health and green technology)

The following statement was delivered by Shri Saurabh Chandra, Secretary, Department of Industrial Policy and Promotion (DIPP), Ministry of Commerce and Industry, New Delhi on Monday, 1 October 2012 at the WIPO General Assembly.

In her statement, India stressed that intellectual property norms must not create “monopoly situations which may hinder competition and access to technology”.

Continue Reading

Uncategorized

Report of the WIPO Standing Committee on Copyright and Related Rights to the fiftieth session of the WIPO General Assembly

The fiftieth Series of Meetings of the Assemblies of the Member States of the World Intellectual Property Organization (WIPO) is meeting on Geneva from 1 October 2012 to 9 October 2012. Agenda item 26 is the “Report on the Work of the Standing Committee on Copyright and Related Rights (SCCR)” which according to the provisional agenda, is scheduled for discussion on Thursday, 4 October 2012. Continue Reading

Uncategorized

Australia, Chile and New Zealand reply to UN Rapporteur for Right to Health on TPP complaints

KEI has recently learned that 6 of 9 countries ignored a UN Special Rapporteur request to respond to the March 22, 2011 complaint regarding the TPP. We are also disappointed in the comments from the three that did respond. The UN process for dealing with such complaints is somewhat bureaucratic and secretive. Among the three countries that did respond, Australia, Chile and New Zealand, all defended the secrecy of the TPP negotiating text and asserted that the TPP would not violate the right to health. Continue Reading

Uncategorized

Intellectual Property Appellate Board (Chennai) dismisses Bayer’s request for a stay on compulsory license for sorafenib

On 12 March 2012 the Controller General of Patents,Designs & Trademarks of India issued an order granting a compulsory license under Section 84 of the Patents Act (1970) to Natco in patent number 215758 granted to Bayer covering the anti-drug sorafenib toslyate. KEI filed an affidavit in this compulsory licensing dispute involving Natco and Bayer. Following the issuance of a compulsory license, Bayer requested the Intellectual Property Appellate Board (IPAB) to issue a stay on the compulsory license.

Continue Reading

Uncategorized

September 2011: Spotlight on India at the WTO Trade Policy Review

On 14 September 2011 and 16 September 2011, the World Trade Organization (WTO) undertook a trade policy review of India. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually the WTO General Council — comprising the WTO’s full membership — operating under special rules and procedures” (Source: WTO, Trade Policy Reviews: Brief Introduction). Continue Reading

SCCR24: India on Contribution of the SCCR to the implementation of the respective Development Agenda recommendations

INDIA: Thank you, Mr. Chairman. Indian Delegation joins the distinguished Delegations of Iran, Egypt, South Africa in supporting the statement by the Distinguished Delegate and leader of the Development Agenda Group, the Brazil Indian Delegate. The Development Agenda recommendations and goals have achieved recent success in the Beijing spirit when we included the paragraphs, the preamble of the new treaty. And from there we have been listing — participating in the norm setting activities, in the limitations and exceptions.

Continue Reading